Yan Deng

904 total citations · 1 hit paper
38 papers, 668 citations indexed

About

Yan Deng is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cell Biology. According to data from OpenAlex, Yan Deng has authored 38 papers receiving a total of 668 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Cardiology and Cardiovascular Medicine and 6 papers in Cell Biology. Recurrent topics in Yan Deng's work include melanin and skin pigmentation (5 papers), Diet and metabolism studies (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Yan Deng is often cited by papers focused on melanin and skin pigmentation (5 papers), Diet and metabolism studies (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Yan Deng collaborates with scholars based in China, United States and Iran. Yan Deng's co-authors include Tao Li, Maodi Xie, Qian Li, Wei Ou, Chunling Jiang, Hai Yu, Xuewen Xu, Shisheng Wang, Yaohui Chen and Meng Gong and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Circulation Research.

In The Last Decade

Yan Deng

34 papers receiving 659 citations

Hit Papers

Targeting Mitochondria-Inflammation Circuit by β-Hydroxyb... 2020 2026 2022 2024 2020 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yan Deng China 12 247 241 159 78 76 38 668
Tomi Tuomainen Finland 15 211 0.9× 369 1.5× 129 0.8× 79 1.0× 61 0.8× 25 807
Goro Katsuumi Japan 13 121 0.5× 271 1.1× 253 1.6× 54 0.7× 69 0.9× 32 660
Xiaozhen Zhuo China 16 130 0.5× 334 1.4× 138 0.9× 79 1.0× 40 0.5× 30 733
Liqing Jiang China 13 186 0.8× 289 1.2× 77 0.5× 86 1.1× 62 0.8× 42 717
Qinqiang Long China 13 168 0.7× 386 1.6× 156 1.0× 56 0.7× 27 0.4× 34 650
Yoshitake Cho United States 16 174 0.7× 462 1.9× 209 1.3× 96 1.2× 86 1.1× 27 781
Eric E. Essick United States 9 206 0.8× 229 1.0× 132 0.8× 47 0.6× 47 0.6× 10 633
Olesya Ilkun United States 10 336 1.4× 473 2.0× 257 1.6× 121 1.6× 105 1.4× 12 864
Jipeng Ma China 16 206 0.8× 327 1.4× 84 0.5× 50 0.6× 43 0.6× 29 689
Lisa Bettcher United States 14 133 0.5× 444 1.8× 187 1.2× 54 0.7× 35 0.5× 21 708

Countries citing papers authored by Yan Deng

Since Specialization
Citations

This map shows the geographic impact of Yan Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Deng more than expected).

Fields of papers citing papers by Yan Deng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Deng. The network helps show where Yan Deng may publish in the future.

Co-authorship network of co-authors of Yan Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Yan Deng. A scholar is included among the top collaborators of Yan Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan Deng. Yan Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kong, Yanyan, Jianing Li, Fei Xu, et al.. (2025). Synthesis, preclinical evaluation and pilot clinical study of a P2Y12 receptor targeting radiotracer [18F]QTFT for imaging brain disorders by visualizing anti-inflammatory microglia. Acta Pharmaceutica Sinica B. 15(2). 1056–1069. 5 indexed citations
2.
Sun, Qiu, Yan Deng, Yuying Feng, et al.. (2025). Multiscale biased chemical space remodeling for developing APLNR agonists with anti-HFpEF efficacy. Proceedings of the National Academy of Sciences. 122(18). e2423432122–e2423432122.
3.
Wang, Junyan, et al.. (2025). Comparative effects of pharmacological interventions for the prevention of acute mountain sickness: A systematic review and Bayesian network meta-analysis. Travel Medicine and Infectious Disease. 66. 102868–102868. 1 indexed citations
4.
Wang, Ting, Yan Deng, Wenwen Chen, et al.. (2025). Time-restricted feeding mitigates HFD-induced sarcopenic obesity in aging mice through improving the sensitivity of FGF21. The Journal of Nutritional Biochemistry. 140. 109893–109893. 1 indexed citations
7.
Deng, Yan, Xin Liu, Min Xie, et al.. (2023). Obesity Enables NLRP3 Activation and Induces Myocardial Fibrosis via Hyperacetylation of HADHa. Diabetes. 72(11). 1597–1608. 10 indexed citations
8.
Zhao, Yingying, Yan Deng, Jinjing Liu, et al.. (2023). Vacuolar ATPase subunit H regulates growth development and pathogenicity of Penicillium digitatum. Postharvest Biology and Technology. 199. 112295–112295. 5 indexed citations
9.
Ji, Liwei, Yinghai Liu, Yan Deng, et al.. (2022). Ketone Body β‐Hydroxybutyrate Prevents Myocardial Oxidative Stress in Septic Cardiomyopathy. Oxidative Medicine and Cellular Longevity. 2022(1). 2513837–2513837. 36 indexed citations
10.
Liu, Xin, Yabing Zhang, Yan Deng, et al.. (2022). Mitochondrial protein hyperacetylation underpins heart failure with preserved ejection fraction in mice. Journal of Molecular and Cellular Cardiology. 165. 76–85. 46 indexed citations
11.
Deng, Yan, Maodi Xie, Qian Li, et al.. (2020). Targeting Mitochondria-Inflammation Circuit by β-Hydroxybutyrate Mitigates HFpEF. Circulation Research. 128(2). 232–245. 300 indexed citations breakdown →
12.
Yin, Anlin, Weihua Zhuang, Gongyan Liu, et al.. (2020). Performance of PEGylated chitosan and poly (L-lactic acid-co-ε-caprolactone) bilayer vascular grafts in a canine femoral artery model. Colloids and Surfaces B Biointerfaces. 188. 110806–110806. 20 indexed citations
13.
Na, Yang, Zhou Jiang, Lihong Niu, et al.. (2019). Dosing depending on SIRT3 activity attenuates doxorubicin-induced cardiotoxicity via elevated tolerance against mitochondrial dysfunction and oxidative stress. Biochemical and Biophysical Research Communications. 517(1). 111–117. 19 indexed citations
14.
Deng, Yan, et al.. (2019). Does celebrity spokesperson signal firm performance? Evidence from a drug scandal in China. Finance research letters. 34. 101237–101237. 6 indexed citations
15.
Deng, Yan, Guo Chen, Ronghua Zhou, et al.. (2018). Direct evidence that hypoxia triggers the cardioprotective response of ischemic preconditioning in a dog double-circuit cardiopulmonary bypass model. Life Sciences. 209. 395–402. 1 indexed citations
16.
Zhang, Zhenyu, Yingyi Zhang, Yan Deng, et al.. (2017). Polymerized human placenta haemoglobin attenuates myocardial injury and aortic endothelial dysfunction in a rat model of severe burns. Artificial Cells Nanomedicine and Biotechnology. 46(6). 1141–1145. 5 indexed citations
17.
Deng, Yan, et al.. (2016). [Role of serotoninergic/melatoninergic system in melanin metabolism in melanocytes exposed to serum of rabbits fed with Liuwei Dihuang decoction].. PubMed. 36(10). 1401–1405. 1 indexed citations
18.
Deng, Yan, Yingbao Yang, Jinjun Rao, et al.. (2015). Ameliorative effects of Xue-Fu-Zhu-Yu decoction, Tian-Ma-Gou-Teng-Yin and Wen-Dan decoction on myocardial fibrosis in a hypertensive rat mode. BMC Complementary and Alternative Medicine. 16(1). 56–56. 20 indexed citations
19.
Xi, Baike, Aaron Kennedy, Jared Entin, et al.. (2010). Investigation of the 2006 Drought and 2007 Flood Extremes at the Southern Great Plains Through an Integrative Analysis of Observations (Invited). AGUFM. 2010. 2 indexed citations
20.
Liu, Ying, Lili Wang, & Yan Deng. (2003). Enhancement of antitumor effect of cisplatin against human ovarian carcinoma cells by mifepristone in vivo.. PubMed. 23(3). 242–4. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026